Gribbles Pathology and Sengenics Enter Into Partnership to Deliver Cutting-Edge Genetic Tests
Kuala Lumpur, Malaysia, May 09, 2013 --(PR.com)-- Gribbles Pathology and Sengenics today announced an exclusive partnership to deliver genetic-based clinical tests in Malaysia.
The aim of the partnership, between Gribbles, one of Asia and Australasia’s leading private pathology laboratories and Sengenics, a leading genetic diagnostics company is to make cutting-edge tests more accessible to the general public. A key advantage of the tests is that through the use of genetics, diagnosis can be made earlier and with higher accuracy.
“Gribbles Pathology is the right strategic partner for Malaysia based on their credible brand, strong positioning and commercial channels across the country. We are excited to work closely with Gribbles in promoting our range of tests to the wider community,” said Johan Poole-Johnson, Commercial Director at Sengenics.
Sam Yee, Chief Executive Officer, Gribbles Pathology, said, “We feel that partnering with an established diagnostics company such as Sengenics with its range of globally validated and widely used tests will not only benefit our customers but also maintain our position as a pioneering clinical service provider."
The partnership will focus on providing the CardioSURE® Heart and Stroke genetic test, ThalaSURE®, which is a comprehensive Thalassemia test that screens for all the common DNA markers for Indian, Arab, South-East Asian and Mediterranean populations and LifeSURE®, which covers the lifetime risk of developing 115 major traits and diseases. Gribbles will also be offering Sequenom’s MaterniT21 PLUS non-invasive, pre-natal diagnostic test.
About Gribbles Pathology
Gribbles Pathology Malaysia is part of Healthscope Group. It commenced operations in late 1996 and is now the largest private provider of diagnostic laboratory services in the region. Head-quartered in Petaling Jaya, we employ over 500 staff nationwide and have an established network of 37 electronically linked pathology facilities throughout Peninsular Malaysia, Sabah and Sarawak. Currently Gribbles Malaysia performs tests for over 1.5 million patients per year. We provide medical testing in all disciplines to over 10,000 Medical Practitioners, Hospitals and Corporate Clients.
About Healthscope
Since its inception in 1985 Healthscope has grown to become Australia's largest provider of integrated healthcare. Healthscope plays a vital role in the health and well-being of Australians working cohesively within the medical community to offer innovative services. Healthscope provides private hospital, medical centre and pathology services in every state and territory of Australia.
Healthscope also operates an expanding network of pathology services in New Zealand, Malaysia, Singapore and Vietnam.
About Sengenics
Sengenics was the 1st company outside the USA to offer genomics-based diagnostics services. The key focus areas for the company are Diagnostics and Research Services using next-generation sequencing, protein and DNA microarray technologies. The business model of the company also leverages the translation of joint research projects into patented and commercialized diagnostics tests. Sengenics has established a wide network of partners in the US, Europe and Asia as channels for its products and services. The company has sales offices and genetic testing facilities in four countries.
Gribbles Pathology Contact
Jimmy Yow
jimmy.yow@gribbles.com.my
+60 (0)16 2013 073
www.gribbles.com.my
Sengenics Contact
Buzzlair Voufincci
enquiries@sengenics.com
+60 (0)3 7960 2881
www.sengenics.com
The aim of the partnership, between Gribbles, one of Asia and Australasia’s leading private pathology laboratories and Sengenics, a leading genetic diagnostics company is to make cutting-edge tests more accessible to the general public. A key advantage of the tests is that through the use of genetics, diagnosis can be made earlier and with higher accuracy.
“Gribbles Pathology is the right strategic partner for Malaysia based on their credible brand, strong positioning and commercial channels across the country. We are excited to work closely with Gribbles in promoting our range of tests to the wider community,” said Johan Poole-Johnson, Commercial Director at Sengenics.
Sam Yee, Chief Executive Officer, Gribbles Pathology, said, “We feel that partnering with an established diagnostics company such as Sengenics with its range of globally validated and widely used tests will not only benefit our customers but also maintain our position as a pioneering clinical service provider."
The partnership will focus on providing the CardioSURE® Heart and Stroke genetic test, ThalaSURE®, which is a comprehensive Thalassemia test that screens for all the common DNA markers for Indian, Arab, South-East Asian and Mediterranean populations and LifeSURE®, which covers the lifetime risk of developing 115 major traits and diseases. Gribbles will also be offering Sequenom’s MaterniT21 PLUS non-invasive, pre-natal diagnostic test.
About Gribbles Pathology
Gribbles Pathology Malaysia is part of Healthscope Group. It commenced operations in late 1996 and is now the largest private provider of diagnostic laboratory services in the region. Head-quartered in Petaling Jaya, we employ over 500 staff nationwide and have an established network of 37 electronically linked pathology facilities throughout Peninsular Malaysia, Sabah and Sarawak. Currently Gribbles Malaysia performs tests for over 1.5 million patients per year. We provide medical testing in all disciplines to over 10,000 Medical Practitioners, Hospitals and Corporate Clients.
About Healthscope
Since its inception in 1985 Healthscope has grown to become Australia's largest provider of integrated healthcare. Healthscope plays a vital role in the health and well-being of Australians working cohesively within the medical community to offer innovative services. Healthscope provides private hospital, medical centre and pathology services in every state and territory of Australia.
Healthscope also operates an expanding network of pathology services in New Zealand, Malaysia, Singapore and Vietnam.
About Sengenics
Sengenics was the 1st company outside the USA to offer genomics-based diagnostics services. The key focus areas for the company are Diagnostics and Research Services using next-generation sequencing, protein and DNA microarray technologies. The business model of the company also leverages the translation of joint research projects into patented and commercialized diagnostics tests. Sengenics has established a wide network of partners in the US, Europe and Asia as channels for its products and services. The company has sales offices and genetic testing facilities in four countries.
Gribbles Pathology Contact
Jimmy Yow
jimmy.yow@gribbles.com.my
+60 (0)16 2013 073
www.gribbles.com.my
Sengenics Contact
Buzzlair Voufincci
enquiries@sengenics.com
+60 (0)3 7960 2881
www.sengenics.com
Contact
Sengenics
Buzzlair Voufincci
+60 (0)3 7960 2881
www.sengenics.com
Buzzlair Voufincci
+60 (0)3 7960 2881
www.sengenics.com
Contact
Categories